These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 31364648)
1. The fucoidan from the brown seaweed Ascophyllum nodosum ameliorates atherosclerosis in apolipoprotein E-deficient mice. Yin J; Wang J; Li F; Yang Z; Yang X; Sun W; Xia B; Li T; Song W; Guo S Food Funct; 2019 Aug; 10(8):5124-5139. PubMed ID: 31364648 [TBL] [Abstract][Full Text] [Related]
2. Fucoidan A2 from the Brown Seaweed Ascophyllum nodosum Lowers Lipid by Improving Reverse Cholesterol Transport in C57BL/6J Mice Fed a High-Fat Diet. Yang Z; Liu G; Wang Y; Yin J; Wang J; Xia B; Li T; Yang X; Hou P; Hu S; Song W; Guo S J Agric Food Chem; 2019 May; 67(20):5782-5791. PubMed ID: 31055921 [TBL] [Abstract][Full Text] [Related]
3. The fucoidan A3 from the seaweed Ascophyllum nodosum enhances RCT-related genes expression in hyperlipidemic C57BL/6J mice. Yang Z; Yin J; Wang Y; Wang J; Xia B; Li T; Yang X; Hu S; Ji C; Guo S Int J Biol Macromol; 2019 Aug; 134():759-769. PubMed ID: 31100394 [TBL] [Abstract][Full Text] [Related]
4. A comparative study of the hypolipidemic effects and mechanisms of action of Liu T; Wang X; Wang YM; Sui FR; Zhang XY; Liu HD; Ma DY; Liu XX; Guo SD Food Funct; 2024 Jun; 15(11):5955-5971. PubMed ID: 38738998 [TBL] [Abstract][Full Text] [Related]
5. Zhang Y; Liu T; Qu ZJ; Wang X; Song WG; Guo SD Cardiovasc Ther; 2024; 2024():8649365. PubMed ID: 38375358 [TBL] [Abstract][Full Text] [Related]
6. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice. Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220 [TBL] [Abstract][Full Text] [Related]
7. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice. Bujold K; Mellal K; Zoccal KF; Rhainds D; Brissette L; Febbraio M; Marleau S; Ong H Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196 [TBL] [Abstract][Full Text] [Related]
9. Medium-chain triglycerides promote macrophage reverse cholesterol transport and improve atherosclerosis in ApoE-deficient mice fed a high-fat diet. Zhang X; Zhang Y; Liu Y; Wang J; Xu Q; Yu X; Yang X; Liu Z; Xue C Nutr Res; 2016 Sep; 36(9):964-973. PubMed ID: 27632916 [TBL] [Abstract][Full Text] [Related]
10. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice. Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841 [TBL] [Abstract][Full Text] [Related]
11. Fucoidan alleviates high-fat diet-induced dyslipidemia and atherosclerosis in ApoE(shl) mice deficient in apolipoprotein E expression. Yokota T; Nomura K; Nagashima M; Kamimura N J Nutr Biochem; 2016 Jun; 32():46-54. PubMed ID: 27142736 [TBL] [Abstract][Full Text] [Related]
12. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice. Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917 [TBL] [Abstract][Full Text] [Related]
13. Ezetimibe promotes CYP7A1 and modulates PPARs as a compensatory mechanism in LDL receptor-deficient hamsters. Xia B; Lin P; Ji Y; Yin J; Wang J; Yang X; Li T; Yang Z; Li F; Guo S Lipids Health Dis; 2020 Feb; 19(1):24. PubMed ID: 32035489 [TBL] [Abstract][Full Text] [Related]
14. Lactobacillus acidophilus ATCC 4356 prevents atherosclerosis via inhibition of intestinal cholesterol absorption in apolipoprotein E-knockout mice. Huang Y; Wang J; Quan G; Wang X; Yang L; Zhong L Appl Environ Microbiol; 2014 Dec; 80(24):7496-504. PubMed ID: 25261526 [TBL] [Abstract][Full Text] [Related]
15. Reduced VLDL clearance in Apoe(-/-)Npc1(-/-) mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels. Ishibashi M; Masson D; Westerterp M; Wang N; Sayers S; Li R; Welch CL; Tall AR J Lipid Res; 2010 Sep; 51(9):2655-63. PubMed ID: 20562239 [TBL] [Abstract][Full Text] [Related]
16. Hawthorn (Crataegus pinnatifida Bunge) leave flavonoids attenuate atherosclerosis development in apoE knock-out mice. Dong P; Pan L; Zhang X; Zhang W; Wang X; Jiang M; Chen Y; Duan Y; Wu H; Xu Y; Zhang P; Zhu Y J Ethnopharmacol; 2017 Feb; 198():479-488. PubMed ID: 28119096 [TBL] [Abstract][Full Text] [Related]
17. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions. Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174 [TBL] [Abstract][Full Text] [Related]
18. Polyphenol-rich black chokeberry (Aronia melanocarpa) extract regulates the expression of genes critical for intestinal cholesterol flux in Caco-2 cells. Kim B; Park Y; Wegner CJ; Bolling BW; Lee J J Nutr Biochem; 2013 Sep; 24(9):1564-70. PubMed ID: 23517916 [TBL] [Abstract][Full Text] [Related]
19. Effects of high dietary fat and cholesterol on expression of PPAR alpha, LXR alpha, and their responsive genes in the liver of apoE and LDLR double deficient mice. Zou Y; Du H; Yin M; Zhang L; Mao L; Xiao N; Ren G; Zhang C; Pan J Mol Cell Biochem; 2009 Mar; 323(1-2):195-205. PubMed ID: 19067122 [TBL] [Abstract][Full Text] [Related]
20. Hepatic Expression of Niemann-Pick C1-Like 1, a Cholesterol Reabsorber from Bile, Exacerbates Western Diet-Induced Atherosclerosis in LDL Receptor Mutant Mice. Yamamoto H; Yamanashi Y; Takada T; Mu S; Tanaka Y; Komine T; Suzuki H Mol Pharmacol; 2019 Jul; 96(1):47-55. PubMed ID: 31064810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]